ABSTRACTThe following list contains master's theses and doctoral dissertations related to the discipline of pharmacy administration for the period 1993 to 2000. This list begins where the previous bibliography listing master's theses and doctoral dissertations work in pharmaceutical marketing and management for the period 1985 to 1992 left off (Journal of Marketing and Management, Vol. 8(1) 1994 by David J. McCaffrey III and Lisa Ruby Basara). The master's theses and doctoral dissertations for this publication were obtained through a survey of pharmacy schools having graduate programs in pharmacy administration. Missing information for dissertations was found using Dissertation Abstracts Online.The list of theses and dissertations was originally separated into categories of economics, education, management, marketing, outcomes research, and social/behavioral sciences. The classification into these specific subject areas in many instances may be debatable but was left up to the interpretation of those gath...
摘要以下是1993 - 2000年药学管理学科的硕士和博士学位论文。这个列表从之前的参考书目开始，其中列出了1985年至1992年期间制药营销和管理领域的硕士论文和博士论文(《营销与管理杂志》，1994年第8卷第1期，作者:David J. McCaffrey III和Lisa Ruby Basara)。本出版物的硕士论文和博士论文是通过对拥有药学管理研究生课程的药学院的调查获得的。论文缺失的信息被发现使用论文摘要在线。论文列表最初分为经济学、教育学、管理学、市场营销学、成果研究和社会/行为科学等类别。在许多情况下，对这些特定主题领域的分类可能是有争议的，但留给那些迦特的解释。
{"title":"A Bibliography of Pharmacy Administration Master's Theses and Doctoral Dissertations 1993–2000","authors":"J. Johnson, S. Madhavan","doi":"10.3109/J058V15N03_07","DOIUrl":"https://doi.org/10.3109/J058V15N03_07","url":null,"abstract":"ABSTRACTThe following list contains master's theses and doctoral dissertations related to the discipline of pharmacy administration for the period 1993 to 2000. This list begins where the previous bibliography listing master's theses and doctoral dissertations work in pharmaceutical marketing and management for the period 1985 to 1992 left off (Journal of Marketing and Management, Vol. 8(1) 1994 by David J. McCaffrey III and Lisa Ruby Basara). The master's theses and doctoral dissertations for this publication were obtained through a survey of pharmacy schools having graduate programs in pharmacy administration. Missing information for dissertations was found using Dissertation Abstracts Online.The list of theses and dissertations was originally separated into categories of economics, education, management, marketing, outcomes research, and social/behavioral sciences. The classification into these specific subject areas in many instances may be debatable but was left up to the interpretation of those gath...","PeriodicalId":16734,"journal":{"name":"Journal of Pharmaceutical Marketing & Management","volume":"29 1","pages":"77-115"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90701321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G. Wellman, D. Pathak, J. Schommer, S. Schweikhart
ABSTRACTThe objective of this study was to develop an understanding of the impact of drug attributes on preference, for decision makers. Conjoint analysis of physicians, pharmacists, and consumers was conducted in an Ohio PPO. Subjects rated drug scenarios that varied on select attributes. Functional status was the noneconomic attribute with the greatest impact on preference. Frequency of administration and side effects were the factors that had the least impact. Physicians, pharmacists, and consumers did not tend to differ in the relative importance placed on noneconomic attributes. These three groups did differ in the manner in which they incorporated cost into the drug selection process.
{"title":"Drug Attributes and Patient Out-of-Pocket Cost Impact on Preference: Conjoint Analysis of Physicians, Pharmacists, and Consumers","authors":"G. Wellman, D. Pathak, J. Schommer, S. Schweikhart","doi":"10.3109/J058V15N02_04","DOIUrl":"https://doi.org/10.3109/J058V15N02_04","url":null,"abstract":"ABSTRACTThe objective of this study was to develop an understanding of the impact of drug attributes on preference, for decision makers. Conjoint analysis of physicians, pharmacists, and consumers was conducted in an Ohio PPO. Subjects rated drug scenarios that varied on select attributes. Functional status was the noneconomic attribute with the greatest impact on preference. Frequency of administration and side effects were the factors that had the least impact. Physicians, pharmacists, and consumers did not tend to differ in the relative importance placed on noneconomic attributes. These three groups did differ in the manner in which they incorporated cost into the drug selection process.","PeriodicalId":16734,"journal":{"name":"Journal of Pharmaceutical Marketing & Management","volume":"72 1","pages":"47-61"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88383872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ABSTRACTThis study investigates the influence of role conflict, role ambiguity, and role strain on job performance, job satisfaction, and life satisfaction among field sales and company sales support employees in a single pharmaceutical company. Because this study is based on data from a single company, these results may not necessarily be generalized to all companies in the industry. In the present research, a path model of the process reveals important variations in response to role conflict, role ambiguity, and role strain between the two classes of employees. For both classes, the influence of decreased role ambiguity is generally positive for measured outcomes. However, reductions in role conflict, while lessening role strain, are likely to result in lower job performance for field sales employees. Decreases in role strain, while improving life satisfaction, may lead to lower job satisfaction for sales support employees.
{"title":"A Model of Job Performance, Job Satisfaction, and Life Satisfaction Among Sales and Sales Support Employees at a Pharmaceutical Company","authors":"M. Prince, Robert L. Engle, K. Laird","doi":"10.3109/J058V16N01_06","DOIUrl":"https://doi.org/10.3109/J058V16N01_06","url":null,"abstract":"ABSTRACTThis study investigates the influence of role conflict, role ambiguity, and role strain on job performance, job satisfaction, and life satisfaction among field sales and company sales support employees in a single pharmaceutical company. Because this study is based on data from a single company, these results may not necessarily be generalized to all companies in the industry. In the present research, a path model of the process reveals important variations in response to role conflict, role ambiguity, and role strain between the two classes of employees. For both classes, the influence of decreased role ambiguity is generally positive for measured outcomes. However, reductions in role conflict, while lessening role strain, are likely to result in lower job performance for field sales employees. Decreases in role strain, while improving life satisfaction, may lead to lower job satisfaction for sales support employees.","PeriodicalId":16734,"journal":{"name":"Journal of Pharmaceutical Marketing & Management","volume":"16 1","pages":"59-80"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81689455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ABSTRACTSpending on direct-to-consumer advertising (DTCA) of prescription medications has grown to approximately $2 billion a year in the United States (1). The volume of DTCA spending and the potential impact of DTCA on consumers' health care behavior justify the investigation of DTCA. The present descriptive study examines DTCA volume from a consumer perspective and identifies how much DTCA a consumer may encounter in popular magazines. Results indicate that the volume and characteristics of DTCA vary across magazines and medical conditions. Findings identify potential audiences most likely to be targeted, and therefore affected, by DTCA.
{"title":"“Look George, There's Another One!” The Volume and Characteristics of Direct-to-Consumer Advertising in Popular Magazines","authors":"H. Young, R. J. Cline","doi":"10.3109/J058V15N03_03","DOIUrl":"https://doi.org/10.3109/J058V15N03_03","url":null,"abstract":"ABSTRACTSpending on direct-to-consumer advertising (DTCA) of prescription medications has grown to approximately $2 billion a year in the United States (1). The volume of DTCA spending and the potential impact of DTCA on consumers' health care behavior justify the investigation of DTCA. The present descriptive study examines DTCA volume from a consumer perspective and identifies how much DTCA a consumer may encounter in popular magazines. Results indicate that the volume and characteristics of DTCA vary across magazines and medical conditions. Findings identify potential audiences most likely to be targeted, and therefore affected, by DTCA.","PeriodicalId":16734,"journal":{"name":"Journal of Pharmaceutical Marketing & Management","volume":"94 1","pages":"7-21"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73286634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ABSTRACTThe US House of Representatives passed the far-reaching Pharmaceutical Market Access Act in July of 2003. If this bill or any similar language becomes law, the provision of health care would be affected radically on a worldwide basis. The author discusses the implications of such a law for governments, society, the pharmaceutical industry, and consumers, touching on societal expectations for cures and diagnostic procedures, aims and results of government regulation of the pharmaceutical industry, individual responsibility for health, and the situation of research-based and biotech enterprises as shouldering both social and commercial responsibility for health care. The author also addresses the economic risks of research-based and biotech enterprises, the need for transparency in cost structure, the funding of R&D, marketing costs for new products, the parallel imports market, and the effects of government reimbursement decisions.
{"title":"The Research-Based Pharmaceutical Industry and Society: What Is at Stake in the Future?","authors":"Karl Wündisch","doi":"10.3109/J058V16N01_04","DOIUrl":"https://doi.org/10.3109/J058V16N01_04","url":null,"abstract":"ABSTRACTThe US House of Representatives passed the far-reaching Pharmaceutical Market Access Act in July of 2003. If this bill or any similar language becomes law, the provision of health care would be affected radically on a worldwide basis. The author discusses the implications of such a law for governments, society, the pharmaceutical industry, and consumers, touching on societal expectations for cures and diagnostic procedures, aims and results of government regulation of the pharmaceutical industry, individual responsibility for health, and the situation of research-based and biotech enterprises as shouldering both social and commercial responsibility for health care. The author also addresses the economic risks of research-based and biotech enterprises, the need for transparency in cost structure, the funding of R&D, marketing costs for new products, the parallel imports market, and the effects of government reimbursement decisions.","PeriodicalId":16734,"journal":{"name":"Journal of Pharmaceutical Marketing & Management","volume":"2 1","pages":"21-40"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80922908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ABSTRACTThe introduction of new technologies in health care, especially for pharmaceuticals, has been insufficiently investigated. Furthermore, the literature may be incomplete or misleading due to the absence of adequate databases to mine, along with the use of outmoded methodologies. This study on the Illinois Triplicate Prescription Control Program data uses the Bass model, a technique of evaluation in marketing, to examine a new pharmaceutical product diffusion, the fentanyl patch. We sought to estimate the relative importance of the interpersonal “word of mouth” influence and the external influence on prescribing. The study results indicated that, unlike traditional diffusion models that emphasize interpersonal influence, the diffusion of the fentanyl patch in the 1990s predominantly depended on external influence. Pharmaceutical marketing managers may find this approach relevant to specifically tailoring their strategies to markets that they have not yet penetrated. Moreover, health policymakers can...
{"title":"Internal and External Influences on the Adoption of the Fentanyl Patch","authors":"Swu-Jane Lin, S. Crawford, J. Salmon","doi":"10.3109/J058V15N04_05","DOIUrl":"https://doi.org/10.3109/J058V15N04_05","url":null,"abstract":"ABSTRACTThe introduction of new technologies in health care, especially for pharmaceuticals, has been insufficiently investigated. Furthermore, the literature may be incomplete or misleading due to the absence of adequate databases to mine, along with the use of outmoded methodologies. This study on the Illinois Triplicate Prescription Control Program data uses the Bass model, a technique of evaluation in marketing, to examine a new pharmaceutical product diffusion, the fentanyl patch. We sought to estimate the relative importance of the interpersonal “word of mouth” influence and the external influence on prescribing. The study results indicated that, unlike traditional diffusion models that emphasize interpersonal influence, the diffusion of the fentanyl patch in the 1990s predominantly depended on external influence. Pharmaceutical marketing managers may find this approach relevant to specifically tailoring their strategies to markets that they have not yet penetrated. Moreover, health policymakers can...","PeriodicalId":16734,"journal":{"name":"Journal of Pharmaceutical Marketing & Management","volume":"3 1","pages":"53-67"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82036435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ABSTRACTIn the pharmaceutical world of today, large, global pharmaceutical companies with their portfolio of “super brands” threaten to dominate to the exclusion of smaller manufacturers. By using sophisticated brand modeling techniques, smaller players can still compete successfully. In the following paper, we explore how UCB has used brand modeling to ensure that its antiepileptic drug, Keppra®, succeeds against competitor brands with much greater resources.
ABSTRACTThe purpose of this study was to determine the perceptions of primary care physicians regarding the effects of direct-to-consumer advertising (DTCA) of prescription drugs. A self-administered questionnaire was mailed to 372 primary care physicians belonging to the National Association of Managed Care Physicians. A total of 76 responses were received, yielding a response rate of 21%. Frequency distributions were done to determine physicians' perceptions. Physicians perceived DTCA to affect their practices by consuming more provider time and increasing the demand for prescription drugs. Physicians did not consider DTCA to have any educational value for patients. Moreover, seven out of ten physicians felt that DTCA gives patients a distorted view of prescription drugs. Physicians considered DTCA to be inappropriate for all classes of drugs except smoking cessation agents. Additionally, physicians differed in their opinion of the effects of DTCA based on number of prescriptions written per day, freque...
{"title":"Effects of Direct-to-Consumer Advertising of Prescription Drugs: Perceptions of Primary Care Physicians","authors":"A. D'souza, B. T. Lively, W. Siganga, M. Goodman","doi":"10.3109/J058V15N03_06","DOIUrl":"https://doi.org/10.3109/J058V15N03_06","url":null,"abstract":"ABSTRACTThe purpose of this study was to determine the perceptions of primary care physicians regarding the effects of direct-to-consumer advertising (DTCA) of prescription drugs. A self-administered questionnaire was mailed to 372 primary care physicians belonging to the National Association of Managed Care Physicians. A total of 76 responses were received, yielding a response rate of 21%. Frequency distributions were done to determine physicians' perceptions. Physicians perceived DTCA to affect their practices by consuming more provider time and increasing the demand for prescription drugs. Physicians did not consider DTCA to have any educational value for patients. Moreover, seven out of ten physicians felt that DTCA gives patients a distorted view of prescription drugs. Physicians considered DTCA to be inappropriate for all classes of drugs except smoking cessation agents. Additionally, physicians differed in their opinion of the effects of DTCA based on number of prescriptions written per day, freque...","PeriodicalId":16734,"journal":{"name":"Journal of Pharmaceutical Marketing & Management","volume":"25 1","pages":"61-75"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83571585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ABSTRACTA scale to examine the impact of the Internet on market structure and competition in the community pharmacy market was developed using the theoretical framework of Porter. A national survey of independent pharmacy managers/owners was conducted. Exploratory factor analysis, coefficient alpha, item-total correlations, and confirmatory factor analysis were used for scale construction and validation. The final market competitive structure scale had 18 items and 5 subscales consistent with Porter's framework. The overall scale reliability was 0.80. Subscale reliabilities ranged from 0.70 to 0.88. The Internet was perceived to have caused an increase in competition in the industry through increases in intensity of rivalry, threat of substitutes, and bargaining power of buyers. The Internet was perceived to have decreased bargaining power of suppliers and threat of new entrants. Although, overall, the Internet was perceived as having increased competition, it was perceived to have slightly increased the ...
{"title":"Development, Validation, and Application of a Scale to Measure the Impact of the Internet on Market Structure and Competition in the Retail Pharmacy Market","authors":"M. Bharmal, J. Thomas","doi":"10.3109/J058V16N01_07","DOIUrl":"https://doi.org/10.3109/J058V16N01_07","url":null,"abstract":"ABSTRACTA scale to examine the impact of the Internet on market structure and competition in the community pharmacy market was developed using the theoretical framework of Porter. A national survey of independent pharmacy managers/owners was conducted. Exploratory factor analysis, coefficient alpha, item-total correlations, and confirmatory factor analysis were used for scale construction and validation. The final market competitive structure scale had 18 items and 5 subscales consistent with Porter's framework. The overall scale reliability was 0.80. Subscale reliabilities ranged from 0.70 to 0.88. The Internet was perceived to have caused an increase in competition in the industry through increases in intensity of rivalry, threat of substitutes, and bargaining power of buyers. The Internet was perceived to have decreased bargaining power of suppliers and threat of new entrants. Although, overall, the Internet was perceived as having increased competition, it was perceived to have slightly increased the ...","PeriodicalId":16734,"journal":{"name":"Journal of Pharmaceutical Marketing & Management","volume":"45 1","pages":"81-99"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78934752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ABSTRACTThe Food and Drug Administration (FDA) has recently attempted to improve the safety of over-the-counter (OTC) drugs by creating a regulation aimed at redesigning their labels. One portion of this regulation attempts to improve the legibility of OTC labels by individually specifying certain elements of their design. The FDA's approach looks at the elements of label design as distinct entities that can be isolated and manipulated to improve legibility. Reality does not match the simplicity of this approach. Legibility is the overall goal in a complex system of interrelated elements that come together to create a message. This research challenges the regulation by using an instrument that measures what is truly important: the legibility of the label.
{"title":"Testing the FDA's Mandate for Over-the-Counter Medication Labels","authors":"Laura Bix, H. Lockhart, F. Cardoso, S. Selke","doi":"10.3109/J058V15N04_03","DOIUrl":"https://doi.org/10.3109/J058V15N04_03","url":null,"abstract":"ABSTRACTThe Food and Drug Administration (FDA) has recently attempted to improve the safety of over-the-counter (OTC) drugs by creating a regulation aimed at redesigning their labels. One portion of this regulation attempts to improve the legibility of OTC labels by individually specifying certain elements of their design. The FDA's approach looks at the elements of label design as distinct entities that can be isolated and manipulated to improve legibility. Reality does not match the simplicity of this approach. Legibility is the overall goal in a complex system of interrelated elements that come together to create a message. This research challenges the regulation by using an instrument that measures what is truly important: the legibility of the label.","PeriodicalId":16734,"journal":{"name":"Journal of Pharmaceutical Marketing & Management","volume":"21 1","pages":"17-36"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82029243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：